Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...

Preclinical findings suggest that psilocybin may protect sensory nerves from chemotherapy toxicity, but clinical trials are ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic ...

An analysis of 12-year results from the C9741 breast cancer trial confirmed the benefit of dose-dense versus conventional chemotherapy for patients with node-positive disease, but also showed ...

Characteristics and Associated Survival of Patients Diagnosed With Non–Small Cell Lung Cancer in a Designated Lung Cancer Program in Western Kenya Induction short-duration immunotherapy at lower doses ...

Chemotherapy-induced nausea and vomiting are among the most distressing side effects of anti-cancer treatment, particularly for those receiving highly emetogenic regimens such as anthracycline plus ...

Association Between Systemic Anticancer Therapy Administration Near the End of Life With Health Care and Hospice Utilization in Older Adults: A SEER Medicare Analysis of End-of-Life Care Quality Novel ...

A chemotherapy-free regimen offered durable disease control for certain patients with advanced breast cancer, according to results of the phase 1/phase 2 ASPIRE trial.The regimen — which consists of ...

High doses of vitamin C could be a new breakthrough in treating cancer. The University of Iowa Health Care Carver College of Medicine has shared results from a randomized, phase 2 trial testing the ...

Chemotherapy-induced nausea and vomiting are among the most distressing side effects of anti-cancer treatment, particularly for those receiving highly emetogenic regimens such as anthracycline plus ...